Last updated: 15 days ago
Moderna, Inc. Financial Report: Mixed Signals as of June 30, 2025
Explore Moderna's Q2 2025 financial report highlighting a net loss of $825M, cash decline, and deferred revenue growth. Investment recommendation: Hold.
Posts With Tag mRNA Vaccines
Showing 1 - 2 of 2 Posts
Last updated: 4 months ago
Moderna, Inc. Q1 2025 Financial Report: Insights & Future Predictions
Explore Moderna's Q1 2025 financial performance, revealing key sales, losses, and strategic recommendations for investors amid evolving market dynamics.